Displaying results 49 - 60 of 91
Liver Tumours

Aiming for ablation in unresectable tumours ≥3 cm: RFA, SIRT or SBRT?

Webcasts
View
Liver Tumours

IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab versus active surveillance in patients with hepatocellular ca...

Webcasts
View
Liver Tumours

Roundtable

Webcasts
View
Liver Tumours

Choosing the first line therapy

Webcasts
View
Liver Tumours

When to switch therapy

Webcasts
View
Liver Tumours

Viral HCC in virosuppressed patients

Webcasts
View
Liver Tumours

Animal models of viral-induced HCC

Webcasts
View
Liver Tumours

Animal models of non-viral-induced HCC

Webcasts
View
Liver Tumours

Phenotypic characteristics of primary liver cancer in a large French cohort of patients with viral chronic liver disease follo...

Webcasts
View
Liver Tumours

Roundtable

Webcasts
View
Liver Tumours

Portal hypertension

Webcasts
View
Liver Tumours

Intra-arterial therapies in combination with immunotherapy

Webcasts
View
Displaying results 49 - 60 of 91